rs876657679
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_017721.5(CC2D1A):c.748+1G>T variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.000000691 in 1,446,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )
Consequence
CC2D1A
NM_017721.5 splice_donor, intron
NM_017721.5 splice_donor, intron
Scores
2
4
1
Splicing: ADA: 0.9999
2
Clinical Significance
Conservation
PhyloP100: 3.71
Genes affected
CC2D1A (HGNC:30237): (coiled-coil and C2 domain containing 1A) This gene encodes a transcriptional repressor that binds to a conserved 14-bp 5'-repressor element and regulates expression of the 5-hydroxytryptamine (serotonin) receptor 1A gene in neuronal cells. The DNA binding and transcriptional repressor activities of the protein are inhibited by calcium. A mutation in this gene results in a nonsyndromic form of cognitive disability (MRT3). [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, Cryptic splice site detected, with MaxEntScore 3.5, offset of 4, new splice context is: tagGTgatg. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-13913639-G-T is Pathogenic according to our data. Variant chr19-13913639-G-T is described in ClinVar as [Pathogenic]. Clinvar id is 228325.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-13913639-G-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 6.91e-7 AC: 1AN: 1446844Hom.: 0 Cov.: 31 AF XY: 0.00000139 AC XY: 1AN XY: 718292
GnomAD4 exome
AF:
AC:
1
AN:
1446844
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
718292
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6Uncertain:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Intellectual disability, autosomal recessive 3 Pathogenic:3
Pathogenic, no assertion criteria provided | clinical testing | Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City | Sep 26, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 25, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Nov 26, 2019 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 29, 2022 | Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease and demonstrated complete skipping of exon 6, leading to a premature stop codon (Manzini et al., 2014); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25066123, 28454995, 31130284, 32552793) - |
Intellectual disability Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 15, 2015 | The c.748+1G>T variant in CC2D1A has been reported in 2 Saudi Arabian families w ith spectrum of neurodevelopmental phenotypes, including nonsyndromic intellectu al disability, language impairment, autism spectrum disorder and seizures (Manzi ni 2014). The variant segregated with disease in a reccessive manner in a total of 11 individuals from both families and was absent from large population studie s. This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and was shown to cause skipping of exon 6, resulting in complete loss of CC2D1A protein expression (Manzini 2014). In summary, this variant meets our criteria to be classified as pathogenic for nonsyndromic intellectual disability with or without seizures in an autosomal recessive manner (http://www.partners. org/personalizedmedicine/LMM) based upon segregation studies, absence from contr ols and functional studies. - |
Autism Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | Centre for Addiction & Mental Health, Centre for Addiction & Mental Health | - | Putative loss-of-function variant, biallelic, in known disease gene; effect of canonical splice donor variant not yet validated - |
Premature ovarian failure 19 Uncertain:1
Uncertain significance, flagged submission | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 25, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at